Literature DB >> 18707541

Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs.

Nianxiang Zou1, Shien Tsai, Shaw-Huey Feng, Tamara Newsome, Hyung-Yong Kim, Bingjie Li, Shimin Zhang, Shyh-Ching Lo.   

Abstract

Burkholderia pseudomallei and Burkholderia mallei are two closely related gram-negative bacterial species classified by the CDC as category B biowarfare agents. To develop monoclonal antibodies (MAbs) that can recognize as many different strains and/or clinical isolates of these two pathogens as possible, we immunized mice with heat-killed bacterial whole cells and membrane preparations from multiple strains and/or clinical isolates of B. pseudomallei and B. mallei. More than 100 different hybridoma clones that produced MAbs strongly reacting to B. pseudomallei and/or B. mallei have been developed. These MAbs were categorized into eight different groups according to their reaction specificity against different species of Burkholderia bacteria as well as the different nature of target antigens (LPS, capsule polysaccharides, proteins, and glycoproteins) on the bacteria they recognized. Characterization of this large panel of MAbs has demonstrated an interesting pattern of various antigenic epitopes shared by the different species of Burkholderia bacteria. More importantly, this study has revealed a pathogenicity-linked antigen epitope(s) on capsule-like polysaccharides found only in the pathogenic species of Burkholderia bacteria and a Burkholderia-specific antigen epitope(s) that did not exist in other gram-negative bacterial species. Our MAbs should prove to be highly valuable in the development of detection, diagnosis, and therapeutic applications against B. mallei and B. pseudomallei infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707541     DOI: 10.1089/hyb.2008.0012

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  10 in total

1.  Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.

Authors:  Andrew E Scott; Mary N Burtnick; Margaret G M Stokes; Adam O Whelan; E Diane Williamson; Timothy P Atkins; Joann L Prior; Paul J Brett
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

2.  Flagellar glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Andrew E Scott; Susan M Twine; Kelly M Fulton; Richard W Titball; Angela E Essex-Lopresti; Timothy P Atkins; Joann L Prior
Journal:  J Bacteriol       Date:  2011-05-20       Impact factor: 3.490

3.  A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.

Authors:  Wildaliz Nieves; Hailey Petersen; Barbara M Judy; Carla A Blumentritt; Kasi Russell-Lodrigue; Chad J Roy; Alfredo G Torres; Lisa A Morici
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

4.  In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Shimin Zhang; Shaw-Huey Feng; Bingjie Li; Hyung-Yong Kim; Joe Rodriguez; Shien Tsai; Shyh-Ching Lo
Journal:  Clin Vaccine Immunol       Date:  2011-03-30

5.  Production and characterization of chimeric monoclonal antibodies against Burkholderia pseudomallei and B. mallei using the DHFR expression system.

Authors:  Hyung-Yong Kim; Shien Tsai; Shyh-Ching Lo; Douglas J Wear; Mina J Izadjoo
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

6.  Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.

Authors:  David P AuCoin; Dana E Reed; Nicole L Marlenee; Richard A Bowen; Peter Thorkildson; Barbara M Judy; Alfredo G Torres; Thomas R Kozel
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

7.  Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia.

Authors:  Shirley Yi Fen Hii; Noor Azila Ali; Norazah Ahmad; Fairuz Amran
Journal:  J Med Microbiol       Date:  2017-10-19       Impact factor: 2.472

Review 8.  An Evolutionary Arms Race Between Burkholderia pseudomallei and Host Immune System: What Do We Know?

Authors:  Chalita Chomkatekaew; Phumrapee Boonklang; Apiwat Sangphukieo; Claire Chewapreecha
Journal:  Front Microbiol       Date:  2021-01-21       Impact factor: 5.640

9.  Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.

Authors:  Mary N Burtnick; Christian Heiss; Rosemary A Roberts; Herbert P Schweizer; Parastoo Azadi; Paul J Brett
Journal:  Front Cell Infect Microbiol       Date:  2012-08-15       Impact factor: 5.293

10.  Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.

Authors:  Eric R Lafontaine; Shawn M Zimmerman; Teresa L Shaffer; Frank Michel; Xiudan Gao; Robert J Hogan
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.